Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 951 results for "aurobindo"

Have money, can't touch it

KOLKATA: Aurobindo could withdraw Rs 4000 after making the rounds of nine ATMs on Thursday. By Friday, he had spent Rs 3500 of it. "I had to pay my maid today. I have deferred all the other payments -the milkman, the laundry man and the cable ... Times of India, 6 hours ago
Sell Yes Bank, hold Aurobindo Pharma: Rajat Bose Money Control, 2 months ago

165 images for aurobindo

Livemint.com, 1 week ago
Livemint.com, 1 week ago
Drug Store News, 14 hours ago
Money Control, 1 week ago
International Business Times India, 1 week ago
The Freepress Journal, 1 week ago
Pharmaceutical Tech.com, 1 week ago
International Business Times India, 5 days ago
Drug Store News, 2 weeks ago
Epoch Times, 1 month ago

Buy Aurobindo Pharma, target Rs 785 : Kunal Bothra

Independent analyst Kunal Bothra has a buy call on Aurobindo Pharma Ltd. with an intra-day target price of Rs 785 .The current market price of Aurobindo Pharma Ltd. is Rs 740.15 Kunal Bothra maintained stop loss at
 Economic Times3 days ago Buy Aurobindo Pharma Ltd. target Rs 768 : Microsec Capital Ltd  Economic Times4 days ago Sell Aurobindo Pharma Ltd. target Rs 680 : Shrikant Chouhan  Economic Times1 week ago Buy Aurobindo Pharma; target of Rs 1060: Centrum  Money Control1 week ago

Aurobindo Pharma's subsidiary signs pact with Teva; Stock pares early gains

Aurobindo Pharma announced last Friday (November 25) that its French subsidiary Arrow Generiques SAS has signed an agreement to acquire select commercial products in France from Teva. Shares of Aurobindo Pharma advanced to Rs 748.85 in early trades, gaining ...
 Sify5 days ago Aurobindo Pharma in spotlight on pact with Teva in France  Capital Market5 days ago Aurobindo to pop Teva pills  The Telegraph1 week ago Aurobindo Pharma provides update on its French subsidairy  Capital Market1 week ago

Company news

Aurobindo Pharma Ltd has received approval from the US Food and Drug Administration for Nevirapine tablets, according to information available on the regulator’s website. Nevirapine, in combination w...
 Business Line3 days ago Mcast and Aurobindo sign MoU  Times of Malta1 month ago Aurobindo Pharma jumps 6.3% after tentative approval for treatment of HIV  India Infoline2 months ago Aurobindo Pharma gains after receiving tentative approval from USFDA for drug  Business Standard2 months ago
[x]  

Aurobindo Pharma buys Teva's calcium & vitamin D3 products in France

The company's French subsidiary, Arrow Generiques, will acquire the right & title in calcium and calcium-vitamin D3 products, including the use of Orocal trademark BS B2B Bureau | Hyderabad November 26, 2016 Last Updated at 11:39 IST Aurobindo ...
 Business Standard India5 days ago Aurobindo’s French unit to buy products from Teva  Business Line1 week ago AUROBINDO PHARMA : Aurobindos French unit to buy products from Teva  4 Traders5 days ago Aurobindo's French unit to buy products from Teva  FirstWord Pharma1 week ago

Stocks in news: Cipla, GAIL, Tata Elxsi, Aurobindo, Ricoh, Uflex

Bharti Airtel | Cipla | GAIL | Idea Cellular | Apollo Tyres | Tata Elxsi | Aurobindo Pharma | Uflex | Dilip Buildcon | ARSS Infra | GPT Infra | Strides Shasun | Ashok Leyland and Ricoh India are stocks, which are in the news today.
 Money Control5 days ago Top buzzing midcap stocks to trade on October 18  Money Control1 month ago Here are a few stocks to keep an eye on September 28  Money Control2 months ago

Pharma shares in focus; Lupin, Sun Pharma, Aurobindo up over 3%

Shares of pharmaceuticals companies were in focus and gained up to 9% on the BSE in intra-day trade following the recent sharp slide of the rupee against the dollar. Lupin, Sun Pharmaceutical Industries, Aurobindo Pharma, Cipla, Cadila Healthcare, ...
 Smart Investor1 week ago Three pharma companies to focus on  Business Standard1 month ago Pharma shares in focus; Lupin, Cipla, Dr Reddys up over 1%  Business Standard India2 days ago Pharma stocks rise after Delhi HC sets aside govt ban on fixed dose combination drugs  Smart Investor2 days ago
[x]  
Finalaya.com

Sensex zooms 360 pts; Tech Mahindra soars 6%, Aurobindo up 4%

Buying interest continued in afternoon trade that pushed equity benchmarks as well as broader markets higher by around 1.5 percent. Technology was the leader in the buying list, followed by FMCG and pharma stocks.
 Money Control1 week ago Markets continue lackadaisical trade; Sensex slips below 26300 level  Finalaya.com1 day ago Sensex, Nifty turn range-bound; GAIL gains over 2.5%  Smart Investor2 days ago Indian benchmarks display spirited performance; Sensex ends above 27450 mark  Finalaya.com3 weeks ago
Money Control

Aurobindo pharma to acquire select products in France from Teva

Both companies intend to ensure continuity of the supply of the products to the market
 Business Standard1 week ago AUROBINDO PHARMA : arm to acquire select products in France from Teva  4 Traders4 days ago Aurobindo Arm To Acquire Select Products In France From Teva  NDTV Profit1 week ago AUROBINDO PHARMA : to acquire select products in France from Teva  4 Traders6 days ago

Aurobindo Pharma inches up after pact with Teva in France

Aurobindo Pharma rose 0.24% to Rs 741.65 at 9:24 IST on BSE after the company said its French subsidiary announced the signing of an agreement to acquire select commercial products in France from Teva.
 Business Standard5 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less